Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data

Authors
Publication date
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fj.jval.2013...
      Last time updated on 03/12/2019